Otsuka Holdings to acquire remaining shares of ReCor Medical

Otsuka Holdings Co., Ltd. announced a merger agreement to acquire the remaining shares of ReCor Medical, Inc. The transaction is subject to ReCor's shareholder approval.

“Otsuka Holdings' acquisition follows the announcement by ReCor on June 15, 2018 that the U.S. Food and Drug Administration has given its approval to initiate a pivotal clinical study, RADIANCE II, for the evaluation of the Paradise® Renal Denervation System for safe and effective reduction of blood ”openminds.com

• 1 source
• openminds.comOtsuka Medical Devices, Otsuka Holdings & ReCor Medical Announce Signing Of Merger Agreement - OPEN MINDSDec 11, 2019

Summarized from public sources; check the original articles before acting on it.